Core Diagnostic Value of Bone Marrow Biopsy Needles

Bone marrow is the core hematopoietic and immune tissue of human body. Abnormal changes in bone marrow cellular morphology, tissue structure and cell ratio are the fundamental basis for diagnosing hematological diseases. Bone marrow biopsy needles are the only standard clinical instrument for obtaining in-situ bone marrow specimens, providing accurate sample support for early screening, definite diagnosis, typing and staging of various blood system diseases.

Application in Benign Hematological Disease Diagnosis

Anemia Classification and Etiological Diagnosis

Various refractory anemias such as iron deficiency anemia, megaloblastic anemia, hemolytic anemia and aplastic anemia cannot be accurately classified only by peripheral blood detection. Complete bone marrow aspiration and core tissue samples obtained by biopsy needles can clarify hematopoietic cell proliferation activity, megakaryocyte distribution and iron metabolism status, realizing accurate etiological diagnosis.

Myelodysplastic Syndromes (MDS) Screening

MDS is characterized by atypical hematopoietic dysplasia. Complete core bone marrow tissues collected by standard biopsy needles help observe cell dysplasia features, bone marrow fibrosis degree and tissue structural abnormalities, providing key basis for early MDS diagnosis and prognostic judgment.

Application in Malignant Hematological Tumor Diagnosis

Leukemia Typing and Staging

Bone marrow biopsy needles obtain sufficient tumor cell samples, supporting morphological observation, immunophenotyping and genetic testing of acute and chronic leukemia. Accurate specimen collection ensures precise leukemia typing and guides subsequent chemotherapy and targeted therapy schemes.

Lymphoma Staging and Bone Marrow Invasion Assessment

Lymphoma bone marrow invasion is an important basis for tumor staging. Bone marrow core samples detected by biopsy needles can judge whether lymphoma cells infiltrate the medullary cavity, clarify clinical staging, and provide accurate evidence for radiotherapy, chemotherapy and immunotherapy strategy formulation.

Post-Treatment Efficacy Monitoring and Recurrence Prevention

During and after tumor treatment, regular bone marrow biopsy through standard needles can dynamically monitor hematopoietic function recovery, minimal residual disease status and tumor cell activity. It helps clinicians evaluate treatment efficacy, adjust medication schemes in time and early warn of disease recurrence.

Bone Marrow Transplantation Matching Evaluation

Before allogeneic bone marrow transplantation, bone marrow specimens are collected by biopsy needles to evaluate the patient's own hematopoietic microenvironment, cell activity and immune status, providing important reference for donor matching, transplantation scheme formulation and postoperative rejection risk prediction.